Exagen (XGN) Fundamental Analysis: Revenue, Earnings & Valuation

7.40 / 10

Outperform

Fundamentals rate Outperform, scoring 7.4/10. Revenue‑MV and operating cash‑flow growth drive strength; Asset‑MV and cash‑up lag. Weighted factor analysis highlights Revenue‑MV (+0.73) and cash‑flow per share (+0.18) as key contributors.

Analysis Checks(2/10)

Revenue-MV

Value-0.27

Score3/3

Weight72.67%

1M Return7.98%

Net cash flow from operating activities per share (YoY growth rate %)

Value21.00

Score2/3

Weight17.96%

1M Return2.28%

PB-ROE

Value0.81

Score0/3

Weight-7.84%

1M Return-1.30%

Basic earnings per share (YoY growth rate %)

Value-12.05

Score1/3

Weight5.02%

1M Return0.59%

Total profit (YoY growth rate %)

Value-31.76

Score1/3

Weight11.47%

1M Return1.41%

Net cash flow from operating activities (YoY growth rate %)

Value-2.61

Score1/3

Weight7.72%

1M Return1.00%

Cash-UP

Value-0.15

Score1/3

Weight5.22%

1M Return0.66%

Diluted earnings per share (YoY growth rate %)

Value-12.05

Score1/3

Weight5.46%

1M Return0.65%

Asset-MV

Value-0.55

Score0/3

Weight-6.91%

1M Return-0.96%

Cash-MV

Value0.02

Score0/3

Weight-10.76%

1M Return-1.72%

Is XGN undervalued or overvalued?

XGN scores 7.40/10 on fundamentals and holds a Discounted valuation at present. Backed by its -147.85% ROE, -29.97% net margin, -3.63 P/E ratio, 4.15 P/B ratio, and -12.05% earnings growth, these metrics solidify its Outperform investment rating.